Description
GDC-6036 is a KRAS G12C covalent inhibitor.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-6036 is a KRAS G12C covalent inhibitor.
Cas No. | 2417987-45-0 |
---|---|
Purity | ≥98% |
Formula | C29H32ClF4N7O2 |
Formula Wt. | 622.07 |
IUPAC Name | 1-[(3S)-4-[7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one |
Synonym | GDC6036 |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Cascetta P, Marinello A, Lazzari C, et al. KRAS in NSCLC: state of the art and future perspectives. Cancers (Basel). 2022 Nov 4;14(21):5430. PMID: 36358848
PDK1 and Akt inhibitor.
R-type Ca2+ and voltage-gated Na+ channel block...
STING inhibitor
Triterpene saponin found in Panax; Kv7.1 K+ cha...
μOR and δOR agonist, D2/D3 DA potentiator.
Non-steroid; AR antagonist.
Bisphosphonate; squalene synthase inhibitor.
Staurosporine analog; PKC inhibitor.
Glycosaminoglycan
GABA analog; GABA potentiator, adenosine A1 ago...
NSAID; COX-1/2 inhibitor.
Synthetic analog of 1,4-naphthoquinone, precurs...
Peptide; calcineurin inhibitor.
Endogenous peptide hormone involved in feeding ...
Organoselenium compound found in selenium-enric...
Bufanolide steroid found in Bufo arenarum;VEGFR...
Nucleoside (guanosine) analog; DNA chain termin...
Antioxidant shown to improve renal function.
AurKA/B inhibitor.
AT1 antagonist.